We are live on ! Find out more
SLNO

Soleno Therapeutics
SLNO

Delisted

SLNO was delisted on the 15th of May, 2026.

Back to rankings

166 hedge funds and large institutions have $2.29B invested in Soleno Therapeutics in 2024 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 78 increasing their positions, 25 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

212% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 25

104% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 24

17% more funds holding

Funds holding: 142 → 166 (+24)

2% less call options, than puts

Call options by funds: $120M | Put options by funds: $123M

4% less capital invested

Capital invested by funds: $2.38B → $2.29B (-$85M)

2.86% less ownership

Funds ownership: 121.22% → 118.37% (-2.9%)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

Holders
166
Holders Change
+24
Holders Change %
+16.9%
% of All Funds
2.18%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.11%
New
49
Increased
78
Reduced
25
Closed
24
Calls
$120M
Puts
$123M
Net Calls
-$2.98M
Net Calls Change
-$23.4M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
+$57.4M
2
Citadel Advisors
Citadel Advisors
Florida
+$49.3M
3
NCM
Nantahala Capital Management
Connecticut
+$34.1M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$20M
5
Holocene Advisors
Holocene Advisors
New York
+$18.7M

Top Sellers

Rank Fund Capital Flow
1
CG
Carlyle Group
District of Columbia
-$140M
2
PA
Perceptive Advisors
New York
-$88.3M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$28.6M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$28.3M
5
Invesco
Invesco
Georgia
-$16.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
51
Farallon Capital Management
California
$4.05M +$4.66M +90,000 New
ABG
52
Ally Bridge Group
New York
$3.94M +$4.54M +87,629 New
NFGH
53
Nan Fung Group Holdings
Hong Kong
$3.58M +$813K +15,700 +25%
EAM
54
Exome Asset Management
New York
$3.47M +$4M +77,285 New
Walleye Capital
55
Walleye Capital
New York
$3.46M +$3.99M +76,934 New
DP
56
Diadema Partners
New Jersey
$3.24M +$3.73M +71,988 New
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$3.21M +$3.7M +71,320 New
ACM
58
Atika Capital Management
New York
$3.18M +$3.66M +70,700 New
CC
59
Checkpoint Capital
California
$3.15M +$624K +12,044 +21%
Bank of New York Mellon
60
Bank of New York Mellon
New York
$3.06M +$221K +4,260 +7%
Rafferty Asset Management
61
Rafferty Asset Management
New York
$2.99M +$510K +9,847 +17%
Nuveen
62
Nuveen
North Carolina
$2.84M +$188K +3,627 +6%
TD Asset Management
63
TD Asset Management
Ontario, Canada
$2.69M -$269K -5,200 -8%
Citigroup
64
Citigroup
New York
$2.42M +$1.91M +36,785 +216%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.3M -$76.5K -1,477 -3%
UBS Group
66
UBS Group
Switzerland
$2.25M +$284K +5,490 +12%
6CM
67
683 Capital Management
New York
$2.25M -$68.5K -1,322 -3%
RAM
68
Readystate Asset Management
Illinois
$2.25M +$2.59M +50,000 New
TCM
69
Tang Capital Management
California
$2.25M +$2.59M +50,000 New
USPCM
70
Union Square Park Capital Management
New York
$2.25M +$2.59M +50,000 New
Bank of America
71
Bank of America
North Carolina
$2.25M +$5.7K +110 +0.2%
FMI
72
F/M Investments
District of Columbia
$2.15M +$2.48M +47,794 New
Swiss National Bank
73
Swiss National Bank
Switzerland
$2.06M +$513K +9,900 +28%
JGC
74
J. Goldman & Co
New York
$2.04M +$1.22M +23,570 +108%
HCA
75
Harbor Capital Advisors
Illinois
$1.68M +$64.7K +1,248 +3%
1 2
3
4 5

SLNO Hedge Fund Activity: Q4 2024 in Review

166 of the 7,602 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q4 2024, worth a combined $2.29B — down 3.6% from $2.38B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new SLNO positions and 24 closed out — a net gain of 25 holders — while 78 added to existing stakes and 25 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $57.4M. The largest seller was Carlyle Group, cutting an estimated $140M.

  • 166 institutional investors held Soleno Therapeutics (SLNO) as of Q4 2024, up from 142 in Q3 2024.
  • Funds reported $2.29B of Soleno Therapeutics stock for Q4 2024, down 3.6% quarter-over-quarter.
  • 49 funds opened new Soleno Therapeutics positions in Q4 2024 and 24 closed out, a net change of +25 holders.
  • The largest Soleno Therapeutics buyer in Q4 2024 was Janus Henderson Group, an estimated $57.4M added.
  • The largest Soleno Therapeutics seller in Q4 2024 was Carlyle Group, an estimated $140M sold.

Based on aggregated 13F filings for Q4 2024.